Microbiome-Targeted Vaccines

The human microbiome plays a crucial role in shaping immune responses and vaccine efficacy. Variations in gut, skin, and respiratory microbiota can influence antibody production, T-cell activation, and overall immunogenicity. Microbiome-targeted interventions, including probiotics, prebiotics, and microbiome-modulating adjuvants, can enhance vaccine effectiveness. Profiling microbiomes allows personalized immunization strategies, ensuring optimal protection for individuals or populations. Understanding host-microbe interactions enables the development of vaccines that work synergistically with the microbiome, opening new avenues for preventive medicine and improving global immunization outcomes.

    Related Conference of Microbiome-Targeted Vaccines

    March 16-17, 2026

    8th World Congress on Vaccine and Immunology

    Paris, France
    September 21-22, 2026

    44th Euro Global Summit and Expo on Vaccines & Vaccination

    Barcelona, Spain

    Microbiome-Targeted Vaccines Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in